Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MRGPRX1 antibody

This anti-MRGPRX1 antibody is a Rabbit Polyclonal antibody detecting MRGPRX1 in ELISA and IHC. Suitable for Human.
Catalog No. ABIN7243574

Quick Overview for MRGPRX1 antibody (ABIN7243574)

Target

See all MRGPRX1 Antibodies
MRGPRX1 (MAS-Related GPR, Member X1 (MRGPRX1))

Reactivity

  • 16
  • 8
  • 4
  • 1
Human

Host

  • 24
Rabbit

Clonality

  • 24
Polyclonal

Conjugate

  • 13
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This MRGPRX1 antibody is un-conjugated

Application

  • 13
  • 6
  • 5
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC)
  • Characteristics

    Polyclonal Antibody

    Purification

    Affinity purification

    Immunogen

    Synthetic peptide of human MRGPRX1

    Isotype

    IgG
  • Application Notes

    IHC 1:50-1:200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C. Avoid freeze / thaw cycles.
  • Target

    MRGPRX1 (MAS-Related GPR, Member X1 (MRGPRX1))

    Alternative Name

    MRGPRX1

    Background

    MRGX1 is an opiod receptor that has been reported exclusively in dorsal root ganglion. MRGX1 is probably involved in the function of nociceptive neurons and may regulate nociceptor function and/or development, including the sensation or modulation of pain. It is potently activated by enkephalins including BAM22 (bovine adrenal medulla peptide 22) and BAM (8-22). BAM22 is the most potent compound and evoked a large and dose-dependent release of intracellular calcium in stably transfected cells.

    NCBI Accession

    NP_671732

    UniProt

    Q96LB2
You are here:
Chat with us!